Holly Hilton
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- Epigenetics and DNA Methylation 3
- Extracellular vesicles in disease 2
- Oncology 6
- Cancer Cells and Metastasis 2
- Cancer-related Molecular Pathways 2
- Co-authors
- Saumya Pant (2 shared papers)Michael E. Burczynski (1 shared paper)Kathryn Packman (2 shared papers)David Heimbrook (2 shared papers)James Rosinski (4 shared papers)Ola Myklebost (1 shared paper)Zoran Filipovic (1 shared paper)Lyubomir T. Vassilev (1 shared paper)
- Journals
- The FASEB Journal (3 papers)PLoS ONE (2 papers)Biomarkers (1 paper)Scientific Reports (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Holly Hilton
19 papers receiving 1.6k citations
Holly Hilton's Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 374
- Oncology 524
- Molecular Biology 1.1k
- Biotechnology 84
- Pulmonary and Respiratory Medicine 287
Countries citing papers authored by Holly Hilton
This map shows the geographic impact of Holly Hilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Hilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Hilton more than expected).
Fields of papers citing papers by Holly Hilton
This network shows the impact of papers produced by Holly Hilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Hilton. The network helps show where Holly Hilton may publish in the future.
Co-authors
The 25 scholars most cited alongside Holly Hilton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy Hit paper breakdown → | 2006 | 553 |
| 2 | 2012 | 385 | |
| 3 | 2009 | 154 | |
| 4 | 2013 | 79 | |
| 5 | 2012 | 75 | |
| 6 | 2003 | 73 | |
| 7 | 2014 | 62 | |
| 8 | 2010 | 43 | |
| 9 | 2016 | 40 | |
| 10 | 2003 | 30 | |
| 11 | 2008 | 29 | |
| 12 | 1994 | 28 | |
| 13 | 2018 | 21 | |
| 14 | 2018 | 20 | |
| 15 | 2009 | 18 | |
| 16 | 2009 | 10 | |
| 17 | 2010 | 8 | |
| 18 | 2013 | 1 | |
| 19 | 2008 | 1 |
About Holly Hilton
Holly Hilton is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Pharmacology, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Medical and Biological Ozone Research (2 papers), Cancer Cells and Metastasis (2 papers), Asthma and respiratory diseases (2 papers), Cancer-related Molecular Pathways (2 papers), Extracellular vesicles in disease (2 papers) and Air Quality and Health Impacts (2 papers). The work is most often cited by research in Cancer Research (374 citations), Oncology (524 citations), Molecular Biology (1.1k citations), Biotechnology (84 citations) and Pulmonary and Respiratory Medicine (287 citations). Holly Hilton has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Saumya Pant, Michael E. Burczynski, Kathryn Packman, David Heimbrook, James Rosinski, Ola Myklebost, Zoran Filipovic, Lyubomir T. Vassilev, Kenneth Kolinsky and Xiaolan Zhao. Their work appears in journals such as The FASEB Journal, PLoS ONE, Biomarkers, Scientific Reports and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.